PSA screening—more data, more debate

被引：3

|

作者：

Sarah Payton

机构：

来源：

Nature Reviews Urology | 2012年 / 9卷 / 2期

关键词：

D O I：

10.1038/nrurol.2012.7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[1] Schizophrenia: More data, less debate
Frangou, Sophia
[J]. SCHIZOPHRENIA RESEARCH, 2022, 242 : 25 - 26
[2] PSA in Screening for Prostate Cancer: More Good than Harm or More Harm than Good?
Duffy, Michael J.
[J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 66, 2014, 66 : 1 - 23
[3] Prostate cancer screening with PSA: new data, old debate
Sciallero, Stefania
Fornarini, Giuseppe
[J]. ONCOLOGY REVIEWS, 2009, 3 (03) : 133 - 135
[4] New Trial Data Do Not End the PSA Screening Debate
Vastag, Brian
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (12) : 844 - 845
[5] PSA screening—a matter of debate?
Isabel Heidegger
[J]. memo - Magazine of European Medical Oncology, 2019, 12 : 244 - 248
[6] French study—PSA screening does more harm than good
[J]. Nature Reviews Clinical Oncology, 2013, 10 (12) : 669 - 669
[7] PSA screening decisions influenced more by patient beliefs than by doctors
Larkin, M
[J]. LANCET, 2002, 359 (9324): : 2172 - 2172
[8] The variability debate: More statistics, more linguistics
Drai, D
Grodzinsky, Y
[J]. BRAIN AND LANGUAGE, 2006, 96 (02) : 157 - 170
[9] Health systems: more evidence, more debate
Feachem, RGA
[J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2000, 78 (06) : 715 - 715
[10] PSA screening-amatter of debate?
Heidegger, Isabel
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (03) : 244 - 248

← 1 2 3 4 5 →